Accuray (ARAY) Short-term Investments (2012 - 2026)

Accuray's (ARAY) quarterly Short-term Investments came in at $467000.0 in Q1 2026, down 60.15% quarter-over-quarter from $1.2 million in Q4 2025.

Accuray (ARAY) Short-term Investments (2012 - 2026) Analysis & Trends

Accuray's Short-term Investments history runs 10 years deep, the most recent figure standing at $467000.0 for Q1 2026.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $467000.0 in Q1 2026; TTM through Mar 2026 was $467000.0, a N/A change from a year earlier, with the FY2024 full-year figure at $485000.0, changed N/A from the prior year.
  • Short-term Investments eased to $467000.0 in Q1 2026 per ARAY's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $1.2 million in Q4 2025 and bottomed at $467000.0 in Q1 2026.
  • The 3-year median for Short-term Investments is $528500.0 (2024), against an average of $674000.0.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn -
10 Accuray 29,832.96 -38.50 Mn 25.29 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 467,000.00
Dec 31, 2025 1.17 Mn
Sep 30, 2025 572,000.00
Jun 30, 2024 485,000.00
Jun 30, 2018 83.08 Mn
Mar 31, 2018 888,000.00
Dec 31, 2017 24.52 Mn
Sep 30, 2017 23.93 Mn
Jun 30, 2017 23.91 Mn
Mar 31, 2017 23.91 Mn
Dec 31, 2016 38.91 Mn
Sep 30, 2016 40.81 Mn
Jun 30, 2016 47.24 Mn
Mar 31, 2016 70.65 Mn
Dec 31, 2015 67.30 Mn
Sep 30, 2015 67.51 Mn
Jun 30, 2015 64.31 Mn
Mar 31, 2015 54.19 Mn
Dec 31, 2014 53.52 Mn
Sep 30, 2014 45.42 Mn